Search research articles
Contact Us
Filters
Showing results (81-90 of 156) with videos related to
Page
of 16
Sort By:
Chinese Journal of Natural Medicines
|
July 12, 2021
New oligomeric neolignans from the leaves of Magnolia officinalis var. biloba
Van-Tuan Vu, Xiao-Juan Xu, Kang Chen, et al.
Polymers
|
April 23, 2022
Nafion Swelling in Salt Solutions in a Finite Sized Cell: Curious Phenomena Dependent on Sample Preparation Protocol
Barry W Ninham, Polina N Bolotskova, Sergey V Gudkov, et al.
Neurology
|
February 20, 2025
Clinically Meaningful Improvement in Physical Fatigue and Muscle Weakness Fatigability with Rozanolixizumab: Post-hoc Analysis of MG Symptoms PRO Responder Rate in the MycarinG study (P4-11.001)
Ali A Habib, Henry J Kaminski, Julian Grosskreutz, et al.
Organic & Biomolecular Chemistry
|
January 14, 2025
Lignan-phloroglucinol hybrids with an unprecedented beadlike core from the leaves of <i>Melicope chunii</i>
Shi-Ying Fan, Li-Hong Hong, Yu-Xia Wang, et al.
Journal of Neurology
|
June 12, 2025
Changes in corticosteroid and non-steroidal immunosuppressive therapy with long-term zilucoplan treatment in generalized myasthenia gravis
Channa Hewamadduma, Miriam Freimer, Angela Genge, et al.
Journal of Analytical Methods in Chemistry
|
August 20, 2021
Pyridinedicarboxylate-Tb(III) Complex-Based Luminescent Probes for ATP Monitoring
Dien Nguyen Thi, Nhung Nguyen Thi, Anh-Tuan Vu, et al.
Environmental Science & Technology
|
January 10, 2025
What Impact Does Net Zero Action on Road Transport and Building Heating Have on Exposure to UK Air Pollution?
Nosha Assareh, Andrew Beddows, Gregor Stewart, et al.
European Journal of Neurology
|
October 16, 2023
Effect of efgartigimod on muscle group subdomains in participants with generalized myasthenia gravis: post hoc analyses of the phase 3 pivotal ADAPT study
Vera Bril, James F Howard, Chafic Karam, et al.
Journal of Neurology
|
January 4, 2023
Efgartigimod improved health-related quality of life in generalized myasthenia gravis: results from a randomized, double-blind, placebo-controlled, phase 3 study (ADAPT)
Francesco Saccà, Carolina Barnett, Tuan Vu, et al.
Annals of Clinical and Translational Neurology
|
August 26, 2025
Durability of Response to B-Cell Maturation Antigen-Directed mRNA Cell Therapy in Myasthenia Gravis
Nizar Chahin, Gregory Sahagian, Marc H Feinberg, et al.
Page
of 16
Search research articles
Search
Showing results (81-90 of 156) with videos related to
Sort By:
Page
of 16
Chinese Journal of Natural Medicines
|
July 12, 2021
New oligomeric neolignans from the leaves of Magnolia officinalis var. biloba
Van-Tuan Vu, Xiao-Juan Xu, Kang Chen, et al.
Polymers
|
April 23, 2022
Nafion Swelling in Salt Solutions in a Finite Sized Cell: Curious Phenomena Dependent on Sample Preparation Protocol
Barry W Ninham, Polina N Bolotskova, Sergey V Gudkov, et al.
Neurology
|
February 20, 2025
Clinically Meaningful Improvement in Physical Fatigue and Muscle Weakness Fatigability with Rozanolixizumab: Post-hoc Analysis of MG Symptoms PRO Responder Rate in the MycarinG study (P4-11.001)
Ali A Habib, Henry J Kaminski, Julian Grosskreutz, et al.
Organic & Biomolecular Chemistry
|
January 14, 2025
Lignan-phloroglucinol hybrids with an unprecedented beadlike core from the leaves of <i>Melicope chunii</i>
Shi-Ying Fan, Li-Hong Hong, Yu-Xia Wang, et al.
Journal of Neurology
|
June 12, 2025
Changes in corticosteroid and non-steroidal immunosuppressive therapy with long-term zilucoplan treatment in generalized myasthenia gravis
Channa Hewamadduma, Miriam Freimer, Angela Genge, et al.
Journal of Analytical Methods in Chemistry
|
August 20, 2021
Pyridinedicarboxylate-Tb(III) Complex-Based Luminescent Probes for ATP Monitoring
Dien Nguyen Thi, Nhung Nguyen Thi, Anh-Tuan Vu, et al.
Environmental Science & Technology
|
January 10, 2025
What Impact Does Net Zero Action on Road Transport and Building Heating Have on Exposure to UK Air Pollution?
Nosha Assareh, Andrew Beddows, Gregor Stewart, et al.
European Journal of Neurology
|
October 16, 2023
Effect of efgartigimod on muscle group subdomains in participants with generalized myasthenia gravis: post hoc analyses of the phase 3 pivotal ADAPT study
Vera Bril, James F Howard, Chafic Karam, et al.
Journal of Neurology
|
January 4, 2023
Efgartigimod improved health-related quality of life in generalized myasthenia gravis: results from a randomized, double-blind, placebo-controlled, phase 3 study (ADAPT)
Francesco Saccà, Carolina Barnett, Tuan Vu, et al.
Annals of Clinical and Translational Neurology
|
August 26, 2025
Durability of Response to B-Cell Maturation Antigen-Directed mRNA Cell Therapy in Myasthenia Gravis
Nizar Chahin, Gregory Sahagian, Marc H Feinberg, et al.
Page
of 16